{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:53:50Z","timestamp":1761519230432,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2014R1A1A2053682"],"award-info":[{"award-number":["NRF-2014R1A1A2053682"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00330-017-5293-y","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T17:02:22Z","timestamp":1523034142000},"page":"3176-3184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer"],"prefix":"10.1007","volume":"28","author":[{"given":"Won Hwa","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-2777","authenticated-orcid":false,"given":"Nariya","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Seon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"5293_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","volume":"378","author":"C Davies","year":"2011","unstructured":"Early Breast Cancer Trialists' Collaborative G, Davies C, Godwin J et al (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378:771\u2013784","journal-title":"Lancet"},{"key":"5293_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0014-2999(84)90493-X","volume":"103","author":"MW MacNab","year":"1984","unstructured":"MacNab MW, Tallarida RJ, Joseph R (1984) An evaluation of tamoxifen as a partial agonist by classical receptor theory\u2013an explanation of the dual action of tamoxifen. Eur J Pharmacol 103:321\u2013326","journal-title":"Eur J Pharmacol"},{"key":"5293_CR3","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1124\/jpet.104.065607","volume":"310","author":"Z Desta","year":"2004","unstructured":"Desta Z, Ward BA, Soukhova NV, Flockhart DA (2004) Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther 310:1062\u20131075","journal-title":"J Pharmacol Exp Ther"},{"key":"5293_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI27987","volume":"116","author":"BJ Deroo","year":"2006","unstructured":"Deroo BJ, Korach KS (2006) Estrogen receptors and human disease. J Clin Invest 116:561\u2013570","journal-title":"J Clin Invest"},{"key":"5293_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/jnci\/djr079","volume":"103","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Warwick J, Pinney E et al (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103:744\u2013752","journal-title":"J Natl Cancer Inst"},{"key":"5293_CR6","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1200\/JCO.2012.44.5015","volume":"31","author":"J Li","year":"2013","unstructured":"Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P (2013) Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol 31:2249\u20132256","journal-title":"J Clin Oncol"},{"key":"5293_CR7","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1186\/bcr3221","volume":"14","author":"J Kim","year":"2012","unstructured":"Kim J, Han W, Moon HG et al (2012) Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Res 14:R102","journal-title":"Breast Cancer Res"},{"key":"5293_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10549-013-2726-4","volume":"142","author":"KL Ko","year":"2013","unstructured":"Ko KL, Shin IS, You JY, Jung SY, Ro J, Lee ES (2013) Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients. Breast Cancer Res Treat 142:559\u2013567","journal-title":"Breast Cancer Res Treat"},{"key":"5293_CR9","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1186\/bcr3451","volume":"15","author":"ME Sandberg","year":"2013","unstructured":"Sandberg ME, Li J, Hall P et al (2013) Change of mammographic density predicts the risk of contralateral breast cancer\u2013a case-control study. Breast Cancer Res 15:R57","journal-title":"Breast Cancer Res"},{"key":"5293_CR10","doi-asserted-by":"crossref","unstructured":"Nyante SJ, Sherman ME, Pfeiffer RM et al (2015) Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer. J Natl Cancer Inst 107","DOI":"10.1093\/jnci\/dju425"},{"key":"5293_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1524-4741.2004.09606.x","volume":"10","author":"PJ Slanetz","year":"2004","unstructured":"Slanetz PJ, Grandpre LE, Yeh ED, Kopans DB, Mendel JB (2004) Effect of tamoxifen on breast tissue density in premenopausal breast cancer. Breast J 10:27\u201332","journal-title":"Breast J"},{"key":"5293_CR12","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1148\/radiographics.18.6.9821201","volume":"18","author":"JW Byng","year":"1998","unstructured":"Byng JW, Yaffe MJ, Jong RA et al (1998) Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 18:1587\u20131598","journal-title":"Radiographics"},{"key":"5293_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1148\/radiology.196.2.7617857","volume":"196","author":"MB Laya","year":"1995","unstructured":"Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L (1995) Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 196:433\u2013437","journal-title":"Radiology"},{"key":"5293_CR14","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1200\/JCO.2008.21.7166","volume":"27","author":"A McTiernan","year":"2009","unstructured":"McTiernan A, Chlebowski RT, Martin C et al (2009) Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol 27:6135\u20136143","journal-title":"J Clin Oncol"},{"key":"5293_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.285.2.171","volume":"285","author":"CM Rutter","year":"2001","unstructured":"Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171\u2013176","journal-title":"JAMA"},{"key":"5293_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1006326432340","volume":"59","author":"EE Sterns","year":"2000","unstructured":"Sterns EE, Zee B (2000) Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable? Breast Cancer Res Treat 59:125\u2013132","journal-title":"Breast Cancer Res Treat"},{"key":"5293_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1148\/radiology.174.2.2136958","volume":"174","author":"PC Stomper","year":"1990","unstructured":"Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE (1990) Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 174:487\u2013490","journal-title":"Radiology"},{"key":"5293_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/jnci\/djh106","volume":"96","author":"J Cuzick","year":"2004","unstructured":"Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621\u2013628","journal-title":"J Natl Cancer Inst"},{"key":"5293_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0009-9236(96)90108-3","volume":"59","author":"F Peyrade","year":"1996","unstructured":"Peyrade F, Frenay M, Etienne MC et al (1996) Age-related difference in tamoxifen disposition. Clin Pharmacol Ther 59:401\u2013410","journal-title":"Clin Pharmacol Ther"},{"key":"5293_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2214\/AJR.13.11109","volume":"202","author":"JY Kim","year":"2014","unstructured":"Kim JY, Cho N, Jeyanth JX et al (2014) Smaller reduction in 3D breast density associated with subsequent cancer recurrence in patients with breast cancer receiving adjuvant tamoxifen therapy. AJR Am J Roentgenol 202:912\u2013921","journal-title":"AJR Am J Roentgenol"},{"key":"5293_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies C, Pan H, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381:805\u2013816","journal-title":"Lancet"},{"key":"5293_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3348\/kjr.2014.15.3.313","volume":"15","author":"SY Ko","year":"2014","unstructured":"Ko SY, Kim EK, Kim MJ, Moon HJ (2014) Mammographic density estimation with automated volumetric breast density measurement. Korean J Radiol 15:313\u2013321","journal-title":"Korean J Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-017-5293-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-5293-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-5293-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T19:55:38Z","timestamp":1554580538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-017-5293-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["5293"],"URL":"https:\/\/doi.org\/10.1007\/s00330-017-5293-y","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"type":"print","value":"0938-7994"},{"type":"electronic","value":"1432-1084"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"assertion":[{"value":"11 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Nariya Cho.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Institutional review board approval was obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was waived by the institutional review board.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"\u2022 retrospective\u2022 observational\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}